Share Data
At Anavex Life Sciences, we strive to produce sustained strong performance and shareholder value.
NASDAQ: AVXL
Key Data
Industry
Biopharmaceutical
Sector
New drug discovery
Fiscal year end
September 30
Shares issued and outstanding
76,018,053 *
Stock purchase warrants
210,000 **
Stock options
11,330,903 **
Fully diluted
87,459,368**
Cash
$152.1 million **
Debt
Nil **
Trading symbol
AVXL
52-week range
$31.50 - $3.65 *
Financial statements and filings
Anavex's filings can be found on EDGAR
Investor relations
Transfer agent
Nevada Agency and Trust
50 West Liberty Street,
Suite 880
Reno, Nevada 89501
Tel: (775) 322-0626
Fax: (775) 322-5623
email: info@natco.org
Resident Agent
email: corpserve@natco.org
Website: www.natco.org
* As at November 19, 2021
** As at September 30, 2021
Forms - Reverse Stock Split
Internal Revenue Service (United States) - Form 8937